Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58.8Revenue (TTM) $M2.6Net Margin (%)-1,472.6Altman Z-Score-24.2
Enterprise Value $M56.9EPS (TTM) $-2.2Operating Margin %-1,404.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-1,472.6Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-27.5Quick Ratio3.1Cash flow > EarningsY
Price/Sales18.25-y EBITDA Growth Rate %-6.0Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-105.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-282.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SNSS is held by these investors:



SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.87-29.2view
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.87-29.2view
Parker Geoffrey M.Director 2016-05-26Buy1,583$2.82-2.84view
Parker Geoffrey M.Director 2016-05-25Buy8,751$2.82-2.84view
Misfeldt DaytonDirector 2015-12-21Buy291,667$5.04-45.63view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy4,167$6.06-54.79view
Ketchum Steven BDirector 2015-07-24Sell1,060$20.76-86.8view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell1,060$20.76-86.8view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell2,119$20.76-86.8view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell105,951$20.76-86.8view

Press Releases about SNSS :

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Sunesis Pharmaceuticals Announces Presentation of Updated Results from Washington University-Sponsor Jun 23 2017 
Lifshitz & Miller LLP Announces Investigation of Anadarko Petroleum Corporation, DryShips Inc., Immu May 15 2017 
Sunesis Pharmaceuticals Reports First Quarter 2017 Financial Results and Recent Highlights May 08 2017 
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sunesis Pharmaceuticals, Inc. for May 02 2017 
SUNESIS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50, May 02 2017 
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sunesis Pharmace May 02 2017 
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sunesis Pharmaceuti May 02 2017 
Sunesis Pharmaceuticals Announces Withdrawal of European Marketing Authorization Application (MAA) f May 01 2017 
Sunesis Pharmaceuticals Announces Presentation of The Ohio State University-Sponsored Preclinical St Apr 03 2017 
Sunesis Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference Mar 28 2017 

More From Other Websites
Sunesis Pharmaceuticals Added to Russell Microcap® Index Jun 26 2017
Sunesis Pharmaceuticals Announces Presentation of Updated Results from Washington... Jun 23 2017
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Sunesis Pharmaceuticals, Inc.... May 19 2017
The Life Sciences Report Examines How Sunesis Pharmaceuticals Shifts Focus to Leukemia Drug May 19 2017
Lifshitz & Miller LLP Announces Investigation of Anadarko Petroleum Corporation, DryShips Inc.,... May 15 2017
Edited Transcript of SNSS earnings conference call or presentation 8-May-17 6:00pm GMT May 12 2017
ETFs with exposure to Sunesis Pharmaceuticals, Inc. : May 11, 2017 May 11 2017
Sunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 May 10 2017
Investor Network: Sunesis Pharmaceuticals, Inc. to Host Earnings Call May 08 2017
Sunesis reports 1Q loss May 08 2017
Sunesis Pharmaceuticals Reports First Quarter 2017 Financial Results and Recent Highlights May 08 2017
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Sunesis... May 04 2017
INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Sunesis... May 03 2017
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Sunesis Pharmaceuticals,... May 03 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Involving Possible... May 03 2017
Blog Coverage Sunesis Pharma Withdraws European Marketing Authorization Application for Vosaroxin May 03 2017
INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Sunesis Pharmaceuticals, Inc. May 02 2017
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sunesis Pharmaceuticals, Inc. for... May 02 2017
SUNESIS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding... May 02 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sunesis... May 02 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}